Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
184A1 |
Human immortalized mammary epithelial cells | ATCC CRL-8798 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | K. Konopka et al., Cell Mol Biol Lett, Jan 2009; 14(1): 70-89 | |||
BT-20 |
Human breast cancer cell line | ATCC HTB-19 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Endres et al., Oncotarget, 2016, 7(39): 64244-64259 | Link | |
DU447 |
Human mammary adenocarcinoma cell line | Human | breast | cell line | iron oxide | Metafectene | publication | L. Matuszewski et al., Radiology, Apr 2005; 235: 155 - 161 | |||||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | plasmid | Metafectene | publication | A. M. Scherbakov et al., J. of Cellular Biochem., 2012, 113: 2147–2155 | ||||
HBL 100 |
Human transformed breast cells | Human | breast | cell line | adherent | plasmid | Metafectene | application note | ![]() |
||||
HC11 |
Mouse immortalized prolactin-responsive mammary epithelial cells | ATCC CRL-3062 | Mouse | breast | cell line | adherent | plasmid | Metafectene | publication | J. Seong., PhD Thesis, Seoul National University | Link | ||
HC11 |
Mouse immortalized prolactin-responsive mammary epithelial cells | ATCC CRL-3062 | Mouse | breast | cell line | adherent | plasmid | Metafectene | publication | J. Seong et al., Development, 2018, 145: dev165258, doi:10.1242/dev.165258 | Link | ||
HT-1080 |
Human breast fibrocarcinoma cell line | ATCC CCL-121 | Human | breast | cell line | adherent | iron oxide | Metafectene | publication | L. Matuszewski et al., Radiology, Apr 2005; 235: 155 - 161 | |||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | GNP-DNA | Metafectene | publication | S. E. Feky et al., ESMO Open, 2018, doi.org/10.1136/esmoopen-2018-EACR25.463 | Link | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | Y. V. Kuznetsov et al., Eur. J. of Medicinal Chemistry, 2018, 143: 670e682, doi.org/10.1016/j.ejmech.2017.11.042 | Link | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Hermawan et al., Dissertation, 2015, Ludwig-Maximilians-Universität München | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | Y. V. Kuznetsov et al., Europ. J. of Med. Chem., 2018, 143: 670-682, doi.org/10.1016/j.ejmech.2017.11.042 | |||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Benito et al., Oncotarget, 2017, 8 (63): 106693-106706 | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | I. V. Rassokhina et al., Steroids, 2016, 113: 29-37; doi.org/10.1016/j.steroids.2016.06.001 | |||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | A. M. Scherbakov et al., IUBMB, 2016, 68 (4): 281-292; DOI 10.1002/iub.1481 | Link | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | X. Ming et al., Am. Ass. for Cancer Res., 2018, DOI: 10.1158/1541-7786.MCR-18-0070 | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | Y. V. Kuznetsov et al., Steroids, 2018, doi.org/10.1016/j.steroids.2018.07.007 | |||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | M. R. Graf et al., J. of Cancer Ther. & Res., 2012, doi: 10.7243/2049-7962-1-25 | Link | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | oligonucleotide | Metafectene | publication | A. M. Tamaddona et al., Iranian J. of Pharm. Sci., 2011, 11: 7(2): 79-87 | Link | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | A. M. Scherbakov et al., Frontiers in Pharmacology, 2018, 8:979, doi: 10.3389/fphar.2017.00979 | Link | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | M. Ansems et al., J Natl Cancer Inst, Jan 2010; 102: 54 - 68 | Link | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene | publication | M. Ansems et al., Breast Cancer Res. Treat., 2015, 149:693–703; DOI: 10.1007/s10549-015-3281-y | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | A. Seifert, Dissertation, 2007, Martin-Luther-Universität | Link | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | M. Lang-Muritano et al., J. of Clinical Endocrinology & Metabolism, 2018, 103(10): 3748–3756 |